- Home
- ENLV vs NCRA Comparison
ENLV vs NCRA Comparison
Compare ENLV & NCRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENLV
- NCRA
- Stock Information
- Founded
- ENLV 2005
- NCRA 2002
- Country
- ENLV Israel
- NCRA Taiwan
- Employees
- ENLV N/A
- NCRA N/A
- Industry
- ENLV Biotechnology: Pharmaceutical Preparations
- NCRA Farming/Seeds/Milling
- Sector
- ENLV Health Care
- NCRA Consumer Staples
- Exchange
- ENLV Nasdaq
- NCRA Nasdaq
- Market Cap
- ENLV 20.7M
- NCRA 16.8M
- IPO Year
- ENLV 1995
- NCRA N/A
- Fundamental
- Price
- ENLV $0.92
- NCRA $0.99
- Analyst Decision
- ENLV Strong Buy
- NCRA
- Analyst Count
- ENLV 2
- NCRA 0
- Target Price
- ENLV $10.00
- NCRA N/A
- AVG Volume (30 Days)
- ENLV 62.6K
- NCRA 20.2K
- Earning Date
- ENLV 06-13-2025
- NCRA 05-14-2025
- Dividend Yield
- ENLV N/A
- NCRA N/A
- EPS Growth
- ENLV N/A
- NCRA N/A
- EPS
- ENLV N/A
- NCRA N/A
- Revenue
- ENLV N/A
- NCRA $20,483,694.00
- Revenue This Year
- ENLV N/A
- NCRA N/A
- Revenue Next Year
- ENLV N/A
- NCRA N/A
- P/E Ratio
- ENLV N/A
- NCRA N/A
- Revenue Growth
- ENLV N/A
- NCRA N/A
- 52 Week Low
- ENLV $0.81
- NCRA $0.70
- 52 Week High
- ENLV $1.84
- NCRA $2.09
- Technical
- Relative Strength Index (RSI)
- ENLV 44.97
- NCRA 54.10
- Support Level
- ENLV $0.86
- NCRA $0.84
- Resistance Level
- ENLV $0.91
- NCRA $1.00
- Average True Range (ATR)
- ENLV 0.06
- NCRA 0.09
- MACD
- ENLV 0.00
- NCRA 0.00
- Stochastic Oscillator
- ENLV 47.06
- NCRA 86.24
About ENLV Enlivex Therapeutics Ltd.
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
About NCRA Nocera Inc.
Nocera Inc is engaged in the manufacturing of aquaculture equipment, construction of aquaculture facilities, managing and operating aquaculture facilities, and consulting for third-party operators of aquaculture facilities. Its primary business operations consist of the design, development, and production of RASs large-scale fish tank systems, for fish farms along with expert consulting, technology transfer, and aquaculture project management services to new and existing aquaculture management business services.